Amgen Inc. Sells Its Stake in Techne Corp.

Amgen Inc. has sold its 5.7% stake in Techne Corp. of Minneapolis.

Amgen, based in Thousand Oaks, sold 1.07 million Techne common shares for $17 each, according to documents filed with the Securities and Exchange Commission. Amgen sold the shares on the open market April 15.

Techne is the parent company for Research and Diagnostic Systems Inc., a specialty manufacturer of biological products.